- Home
- GNTA vs FEIM Comparison
GNTA vs FEIM Comparison
Compare GNTA & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTA
- FEIM
- Stock Information
- Founded
- GNTA 2014
- FEIM 1961
- Country
- GNTA Italy
- FEIM United States
- Employees
- GNTA N/A
- FEIM N/A
- Industry
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- FEIM Electrical Products
- Sector
- GNTA Health Care
- FEIM Industrials
- Exchange
- GNTA Nasdaq
- FEIM Nasdaq
- Market Cap
- GNTA 67.4M
- FEIM 119.5M
- IPO Year
- GNTA 2021
- FEIM N/A
- Fundamental
- Price
- GNTA $5.34
- FEIM $12.80
- Analyst Decision
- GNTA Strong Buy
- FEIM
- Analyst Count
- GNTA 1
- FEIM 0
- Target Price
- GNTA $25.00
- FEIM N/A
- AVG Volume (30 Days)
- GNTA 28.4K
- FEIM 19.0K
- Earning Date
- GNTA 01-01-0001
- FEIM 12-10-2024
- Dividend Yield
- GNTA N/A
- FEIM 7.98%
- EPS Growth
- GNTA N/A
- FEIM N/A
- EPS
- GNTA N/A
- FEIM 0.62
- Revenue
- GNTA N/A
- FEIM $57,943,000.00
- Revenue This Year
- GNTA N/A
- FEIM N/A
- Revenue Next Year
- GNTA N/A
- FEIM N/A
- P/E Ratio
- GNTA N/A
- FEIM $20.24
- Revenue Growth
- GNTA N/A
- FEIM 28.82
- 52 Week Low
- GNTA $2.20
- FEIM $7.20
- 52 Week High
- GNTA $7.28
- FEIM $14.50
- Technical
- Relative Strength Index (RSI)
- GNTA 56.89
- FEIM 52.77
- Support Level
- GNTA $4.89
- FEIM $12.17
- Resistance Level
- GNTA $6.20
- FEIM $12.72
- Average True Range (ATR)
- GNTA 0.70
- FEIM 0.37
- MACD
- GNTA -0.06
- FEIM 0.01
- Stochastic Oscillator
- GNTA 37.32
- FEIM 45.37
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
About FEIM Frequency Electronics Inc.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.